Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-29

Clinical Trial Update: Intraseasonal Short-time Up-dosing With Alutard SQ Grasses [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intraseasonal short-time up-dosing with Alutard SQ Grasses for grass pollen allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alutard SQ Grasses (grass pollen extract)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED